Delivery Order SPE2DB22D3011-SPE2DB26FP7KD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 per unit, with a contract ceiling value of $2,235.80 and an ultimate completion date of November 3, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Armodafinil 250 mg tablets (30-count units) valued at $2,609.44. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count supply) with a ceiling value of $2,024.58. This non-set-aside, competitively awarded contract employs firm fixed price pricing and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same area. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $1,196.97. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,672.50 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on September 18, 2025, with an ultimate completion date of September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,672.35 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of July 11, 2025, and represents a non-competitive set-aside award. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7KDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (quantity 30) on November 6, 2025, with a ceiling value of $1,148.90 and an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. Through its comprehensive prime IDC with DLA, the company supplies a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support military healthcare programs globally. This delivery order exemplifies AmerisourceBergen's role in fulfilling routine pharmaceutical supply requirements for federal healthcare systems, leveraging its extensive contract portfolio and competitive procurement capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/6/25 |